These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 27658792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile.
    Canale V, Rak A, Kotańska M, Knutelska J, Siwek A, Bednarski M, Nowiński L, Zygmunt M, Koczurkiewicz P, Pękala E, Sapa J, Zajdel P.
    Molecules; 2018 Aug 29; 23(9):. PubMed ID: 30158432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and α1-adrenoceptor antagonist activity of tamsulosin analogues.
    Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D.
    Eur J Med Chem; 2010 Dec 29; 45(12):5800-7. PubMed ID: 20934789
    [Abstract] [Full Text] [Related]

  • 5. Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
    Kotańska M, Kulig K, Marcinkowska M, Bednarski M, Malawska K, Zaręba P.
    J Endocrinol Invest; 2018 May 29; 41(5):609-619. PubMed ID: 29110282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C.
    J Med Chem; 1998 Dec 17; 41(26):5320-33. PubMed ID: 9857099
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
    Zaręba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowiński L, Raźny K, Sapa J, Malawska B, Kulig K.
    Bioorg Med Chem; 2015 May 01; 23(9):2104-11. PubMed ID: 25813897
    [Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowiński L, Zygmunt M, Sapa J, Malawska B, Kulig K.
    Arch Pharm (Weinheim); 2015 Dec 01; 348(12):861-7. PubMed ID: 26523954
    [Abstract] [Full Text] [Related]

  • 11. Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.
    Baran M, Kepczyńska E, Zylewski M, Siwek A, Bednarski M, Cegła MT.
    Med Chem; 2014 Mar 01; 10(2):144-53. PubMed ID: 23627274
    [Abstract] [Full Text] [Related]

  • 12. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P, Kurczab R, Grychowska K, Satała G, Pawłowski M, Bojarski AJ.
    Eur J Med Chem; 2012 Oct 01; 56():348-60. PubMed ID: 22926225
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
    Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Centurión D.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):262-9. PubMed ID: 23707349
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.
    Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.
    Bioorg Med Chem; 2015 Dec 15; 23(24):7735-42. PubMed ID: 26643219
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Selective α1A-Adrenoceptor Antagonists.
    Guo D, Li J, Lin H, Zhou Y, Chen Y, Zhao F, Sun H, Zhang D, Li H, Shoichet BK, Shan L, Zhang W, Xie X, Jiang H, Liu H.
    J Med Chem; 2016 Oct 27; 59(20):9489-9502. PubMed ID: 27709945
    [Abstract] [Full Text] [Related]

  • 17. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ.
    Eur Urol; 1999 Oct 27; 36 Suppl 1():2-6. PubMed ID: 10438241
    [Abstract] [Full Text] [Related]

  • 18. Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists.
    Abou-Seri SM, Abouzid K, Abou El Ella DA.
    Eur J Med Chem; 2011 Feb 27; 46(2):647-58. PubMed ID: 21193252
    [Abstract] [Full Text] [Related]

  • 19. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L.
    Eur J Med Chem; 2010 Sep 27; 45(9):3740-51. PubMed ID: 20605276
    [Abstract] [Full Text] [Related]

  • 20. Human α1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.
    Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5910-6. PubMed ID: 25288493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.